Jefferies Financial Group’s Regenxbio RGNX Stock Holding History

Jefferies Financial Group’s Portfolio RGNX Stock Details RGNX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-400,000	Closed	-$5.8M	–	1805
2024 Q3	$5.8M	Buy	+400,000	New	+$4.88M	0.04%	285

Other funds holding RGNX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Jefferies Financial Group's RGNX Position: Q2 2026 in Review

Jefferies Financial Group sold out of Regenxbio (RGNX) in Q2 2026, closing a stake of 95,400 shares — an estimated $799K sold.

Jefferies Financial Group first reported a position in RGNX in Q1 2023 and held it in 2 quarters. The position peaked at $1.27M in Q1 2023. 165 funds tracked by Wall St. Rank hold RGNX as of Q2 2026.

Jefferies Financial Group reported no remaining Regenxbio position as of Q2 2026 after selling out during the quarter.
Jefferies Financial Group sold 95,400 Regenxbio shares in Q2 2026, an estimated $799K.
Jefferies Financial Group first reported a position in Regenxbio in Q1 2023 and held it in 2 quarters.
Jefferies Financial Group's Regenxbio position peaked at $1.27M in Q1 2023.
165 funds tracked by Wall St. Rank held Regenxbio as of Q2 2026.

Based on Jefferies Financial Group's 13F filing for Q2 2026, filed 17 Aug 2026.